Login
Toggle navigation
Videos
Categories
Trending
Gabriele Solarini Paviotti, account relationship leader at Auxiell, interviews Gianmarco Lanza, President and CEO of FAE Technology.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Videointervista Gianmarco Lanza – CEO FAE Technology
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Cutting Through the Noise: Investing Wisely and Understanding the Market | Phil Ball, President , Bollin Wealth Management LLC.
00:10:00
Private Markets Outlook: Global Trends, India's Potential, and Investment Strategy | Rishi Kapoor, CO-CEO, Investcorp Inc.
00:10:00
Western Uranium CEO Unveils Expansion Plans at PDAC 2024 | George Glasier - Director, President and Chief Executive Officer of Western Uranium & Vanadium Corp.
00:10:00
Stavely Minerals Poised to Transform Victoria’s Mining Landscape | Chris Cairns , Managing Director, Stavely Minerals Ltd.
00:10:00
Positioning for Success: Easterly Government Properties' Strengths in an Inflationary Market | Bill Trimble, CEO ,Easterly Government Properties Inc.
00:10:00
Bourbon: A Brief Expression
00:10:00
Witted Megacorp plans IPO | Joe Sheer, CEO, Witted Megacorp OyjWITTED:HEX
00:10:00
Navigating Commercial Real Estate Trends and Technology Integration| Peter M. Mavoides, CEO ,Essential Properties Realty Trust Inc.
00:10:00
Snowline Gold's High-Grade Yukon Discoveries
00:10:00
Innovative Diamond Exploration Solutions with On-Site Processing
00:10:00
PKH Ventures Limited's Expansion into Public Markets, Featuring Construction, Hospitality, and Infrastructure Innovations | Pravin Kumar Agarwal , CMD, PKH Ventures Ltd.
00:10:00
Update on Lundin Gold: On Track for First Gold in a Year